Table 1.
Characteristic | Case | miR-134 | P valuea | |
---|---|---|---|---|
| ||||
Low expression | High expression | |||
Age (years) | 0.365 | |||
<60 | 28 | 14 | 14 | |
≥60 | 26 | 9 | 17 | |
Gender | 0.534 | |||
Male | 33 | 16 | 117 | |
Female | 21 | 9 | 12 | |
Pathologic type | 0.298 | |||
Ulcerative type | 18 | 10 | 8 | |
Medullary type | 16 | 7 | 9 | |
Fungating type | 12 | 5 | 7 | |
Constrictive type | 5 | 0 | 5 | |
Plaque type | 3 | 1 | 2 | |
Other | 1 | 1 | 0 | |
Differentiation | 0.135 | |||
Well | 7 | 2 | 5 | |
Moderate | 24 | 12 | 12 | |
Poor | 23 | 16 | 7 | |
Tumor size | 0.033 | |||
≤4 cm | 26 | 10 | 16 | |
>4 cm | 28 | 21 | 7 | |
TNM Classification | 0.009 | |||
I | 7 | 4 | 3 | |
II | 13 | 9 | 4 | |
III | 25 | 16 | 9 | |
IV | 9 | 7 | 2 | |
Lymph node status | <0.001 | |||
Negative | 25 | 13 | 12 | |
Positive | 29 | 20 | 9 |
One-way ANOVA and t-test were used to analyze the correlation between the expression of miR-134 and clinicopathologic features of the patients.